|
|
Contact Netz. (2013). Jahresbericht 2012. Bern: Author.
Keywords: harm reduction; treatment and maintenance; methadone maintenance; addiction; prevention; counseling; supported accommodation; work; quality; evaluation; Switzerland; annual report; financial statement; drug substitution therapy
|
|
|
|
Réseau Contact. (2013). Rapport annuel 2012. Berne: Réseau Contact.
Keywords: harm reduction; treatment and maintenance; methadone maintenance; addiction; prevention; counseling; supported accommodation; work; quality; evaluation; Switzerland; annual report; financial statement; drug substitution therapy
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). EMCDDA-Europol Joint Report on a new psychoactive substance : 5-(2-aminopropyl)indole. Joint Reports. Luxembourg: Publications Office of the European Union.
Abstract: At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ’5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.
Keywords: psychoactive substances; benzodiazepines; designer drug; research chemical; AOD consumption; risk assessment; AOD intoxication; AODR mortality; AODR crime; government and politics; AOD public policy strategy; law enforcement; rave; Europe; European Union
|
|
|
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2012). Jahresbericht 2012 : Stand der Drogenproblematik in Europa. Jahresbericht. Luxemburg: Amt für Veröffentlichungen der Europäischen Union.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; law enforcement; cannabis; gamma-hydroxybutyric acid; ecstasy; amphetamines; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; ketamine; prevalence; AOD effects and AODR problems; AODR mortality; treatment and maintenance; harm reduction; international area; Europe; annual report
|
|
|
|
Observatoire européen des drogues et des toxicomanies. (2012). Rapport annuel 2012 : état du phénomène de la drogue en Europe. Rapport annuel. Luxembourg: Office des publications de l'Union européenne.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; law enforcement; cannabis; gamma-hydroxybutyric acid; ecstasy; amphetamines; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; ketamine; prevalence; AOD effects and AODR problems; AODR mortality; treatment and maintenance; harm reduction; Europe; annual report
|
|
|
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2012). Relazione annuale 2012 : evoluzione del fenomeno della droga in Europa. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni dellUnione europea.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; law enforcement; cannabis; gamma-hydroxybutyric acid; ecstasy; amphetamines; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; ketamine; prevalence; AOD effects and AODR problems; AODR mortality; treatment and maintenance; harm reduction; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2012). Annual report 2012 : the state of the drugs problem in Europe. Annual report. Luxembourg: Publications Office of the European Union.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; law enforcement; cannabis; gamma-hydroxybutyric acid; ecstasy; amphetamines; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; ketamine; prevalence; AOD effects and AODR problems; AODR mortality; treatment and maintenance; harm reduction; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2013). Drug policy profiles : Ireland. Drug policy profiles. Lisbon: Publications Office of the European Union.
Abstract: The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods of historic development, the report explores: the country’s national strategies; the legal context within which they operate; the public funds spent, or committed, to implement them; and the political bodies and mechanisms set up to coordinate the response to the problem. The profile sets this information in context by outlining the size, wealth and economic situation of the country as a whole, as well as the historical development of the current policy. Also described is the manner in which events in Ireland bear similarities with, and differences from, developments in other European countries.
Keywords: history; AOD public policy strategy; drug offense; law; drug legalization; evaluation; Ireland
|
|
|
|
(2012). Pregnancy, childcare and the family : key issues for Europe's response to drugs (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Publications Office of the European Union.
Abstract: This Selected issue gives a broad overview on the extent of, and available responses to, the problems of pregnant drug users and families that are affected by drug use. In the first part of the report, a description of the available data on the extent of drug use during pregnancy and associated risks is followed by a review of responses to drug use among pregnant women across Europe. The second part of the publication focuses on children living in the care of drug users. Here, a review of the risks related to drug use in the family sets the scene for European overviews of responses targeting drug-using parents and responses aimed at the children of drug users. The policy and legal frameworks concerning the two situations are described, both for pregnant drug users and drug-using parents and their children.
Keywords: AOD use, abuse, and dependence; AOD user; AOD associated consequences; risk; pregnancy; family; parent; child; public policy on health; international area; Europe; European Union
|
|
|
|
Thanki, D., Matias, J., Griffiths, P., Noor, A., Olszewski, D., Simon, R., et al. (2012). Prevalence of daily cannabis use in the European Union and Norway (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Publications Office of the European Union.
Abstract: This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported data regarding frequency of cannabis use from large, probabilistic, nationally representative samples of general population surveys from 20 countries, representing more than 83 % of the population of EU and Norway, were collected through two rounds of ad hoc data collection in 2004 and 2007 and through a routine, standard data collection instrument since 2010.
Keywords: AOD use, abuse, and dependence; AOD consumption; illicit drug; cannabis; prevalence; survey; statistical data; international area; Norway; Europe; European Union
|
|
